IL1B and hepatocellular carcinoma: To the best of our knowledge, this study is the first to show that IL‐1β genetic polymorphisms are associated with mPVI and peripheral blood CTC counts, which may help elucidate the mechanism and treatment of hematogenous dissemination in HCC.